Home Products Most Popular Contact
No items in your cart.
The page below is a sample from the LabCE course Breast Cancer Predictive Markers. Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.

Learn more about Breast Cancer Predictive Markers (online CE course) »
How to Subscribe
Histology CE Package$65 Add to cart
Individual course$20 Add to cart

References

Ashok, M. Analysis of HER2 Testing in Breast Cancer; Disparities, cost effectiveness, and patterns of care [dissertation thesis]. Atlanta, GA: Georgia Institute of Technology; 2009.
Bond™ Oracle™ HER2 IHC System for Leica BOND-MAX System [Instructions for use]. Wetzlar, Germany: Leica Microsystems; 2014.
Cancer.net web site. Follow-up Care for Breast Cancer. December 7, 2015. Available at: http://www.cancer.net/publications-and-resources/what-know-ascos-guidelines/what-know-ascos-guideline-follow-care-breast-cancer. Accessed July 25, 2018.
CAP Commission on Laboratory Accreditation - Laboratory Accreditation Program. Anatomic Pathology Accreditation Checklist. Northfield, IL: 2017.
Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer. 1989; 63:181-187.
Clinical and Laboratory Standards Institute. Quality Assurance for Design Control and Implementation of Immunohistochemistry Assays. 2nd ed. CLSI document I/LA28-A2. Wayne, PA: CLSI; 2011.
Genetech; FDA submission, STN: 103792\5008\0. Trastuzumab, Herceptin®. Submission for final approval, April 2, 2001.
Hammond MEH, Hayes DF, Wolff AC, et al. American Society for Clinical Oncology/College of American Pathologists, Guidelines Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer. Arch Pathol Lab Med. June 2010; 134:48-72. Available at: http://www.archivesofpathology.org/doi/pdf/10.1043/1543-2165-134.7.e48. Accessed July 25, 2018.
Hardy LB, Fitzgibbons PL, Goldsmith JD, et al. Immunohistochemistry Validation Procedures and Practices: A College of American Pathologists Survey of 727 Laboratories. Arch Pathol Lab Med. January 2013; 137(1):19-25. Available at: http://www.archivesofpathology.org/doi/full/10.5858/arpa.2011-0676-CP. Accessed July 25, 2018.
Hartman AK, Gorman BK, Chakraborty S, et al. Determination of HER2/Neu Status. Arch Pathol Lab Med. Apri 2014; 138:553-558. Available at: http://www.archivesofpathology.org/doi/pdf/10.5858/arpa.2013-0314-SA. Accessed July 25, 2018.
Nakhleh RE, Fitzgibbons PL. Quality Management in Anatomic Pathology: Promoting Patient Safety through Systems Improvement and Error Reduction. Northfield, IL: College of American Pathologists; 2005.
Wolf AC, Hammond ME, Hicks DG, et al. Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update. J Clin Oncol. 2013; 31:3997-4013. Available at: http://jco.ascopubs.org/content/31/31/3997.full. Accessed July 25, 2018.
Wolf AC, Hammond ME, Schwartz JN, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol. 2007; 131:118-145.
Yeh I. Measuring HER-2 in Breast Cancer: Immunohistochemistry, FISH, or ELISA? Am J Clin Pathol. 2002; 117(Suppl 1):S26-S35. Available at: https://www.researchgate.net/profile/I_Tien_Yeh/publication/231585094_Measuring_HER-2_in_breast_cancer._Immunohistochemistry_FISH_or_ELISA/links/55bfedf108aec0e5f4476c05.pdf. Accessed July 25, 2018.